You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

CLINICAL TRIALS PROFILE FOR PEGAPTANIB SODIUM

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for PEGAPTANIB SODIUM

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00040313 ↗	Pegaptanib Sodium Compared to Sham Injection in Patients With DME Involving the Center of the Macula	Completed	Eyetech Pharmaceuticals	Phase 2	2002-10-01	The purpose of the study is to determine whether pegaptanib sodium (Macugen) is safe and effective in slowing the leakage of fluid within the retina and thereby stabilizing or improving vision when compared to placebo injections. A total of 176 patients will be enrolled
NCT00087763 ↗	Pegaptanib Sodium on Foveal Thickening in Patients With Exudative Subfoveal Age-Related Macular Degeneration (AMD)	Completed	Pfizer	Phase 2	2004-03-01	The purpose of this study is to determine if Macugen™ reduces foveal thickness and improves vision in patients with wet AMD.
NCT00087763 ↗	Pegaptanib Sodium on Foveal Thickening in Patients With Exudative Subfoveal Age-Related Macular Degeneration (AMD)	Completed	Eyetech Pharmaceuticals	Phase 2	2004-03-01	The purpose of this study is to determine if Macugen™ reduces foveal thickness and improves vision in patients with wet AMD.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for PEGAPTANIB SODIUM

Condition Name

Chart
Table

Condition Name for PEGAPTANIB SODIUM
Intervention	Trials
Macular Degeneration	8
Diabetic Macular Edema	5
Age-related Macular Degeneration	5
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for PEGAPTANIB SODIUM
Intervention	Trials
Macular Degeneration	17
Macular Edema	11
Edema	7
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for PEGAPTANIB SODIUM

Trials by Country

Map
Table

Trials by Country for PEGAPTANIB SODIUM
Location	Trials
United States	91
Japan	38
France	6
Spain	4
Canada	4
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for PEGAPTANIB SODIUM
Location	Trials
Texas	9
California	7
Florida	6
Pennsylvania	5
Michigan	5
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for PEGAPTANIB SODIUM

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for PEGAPTANIB SODIUM
Clinical Trial Phase	Trials
Phase 4	7
Phase 3	4
Phase 2/Phase 3	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for PEGAPTANIB SODIUM
Clinical Trial Phase	Trials
Completed	22
Terminated	6
Withdrawn	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for PEGAPTANIB SODIUM

Sponsor Name

Chart
Table

Sponsor Name for PEGAPTANIB SODIUM
Sponsor	Trials
Pfizer	20
Eyetech Pharmaceuticals	11
Vision Research Foundation	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for PEGAPTANIB SODIUM
Sponsor	Trials
Industry	34
Other	15
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.